Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer

The androgen receptor (AR) plays an essential role in prostate cancer progression and is a key target for prostate cancer treatment. However, patients with prostate cancer undergoing androgen deprivation therapy eventually experience biochemical relapse, with hormone-sensitive prostate cancer progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Mayao, Zhang, Yifan, Xu, Zhuofan, Wu, Chenwei, Ye, Yuedian, Liu, Rui, Lv, Shidong, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708830/
https://www.ncbi.nlm.nih.gov/pubmed/36446767
http://dx.doi.org/10.1038/s41420-022-01257-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708830/
https://www.ncbi.nlm.nih.gov/pubmed/36446767
http://dx.doi.org/10.1038/s41420-022-01257-1

Ejemplares similares